BioSpace News Archive

Nicox SA announced that the United States Patent and Trademark Office (USPTO) has determined that U.S. Patent No. 7,629,345, which covers latanoprostene bunod, commercialized by Bausch + Lomb under the trademark VYZULTA®, is eligible for patent term extension of five years.

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full-year 2023 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, February 14, 2024.

Trinity Biotech plc announced it has entered into a definitive agreement to acquire the biosensor and Continuous Glucose Monitoring assets of privately held Waveform Technologies, Inc. for $12.5 million in cash, 9 million American Depositary Shares of the Company and additional contingent consideration.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced the online publication of a research paper in the Journal Pain.

BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions for cardiovascular disorders, is targeting heart failure and chronic myocardial ischemia as potential indications for its biotherapeutic candidates: autologous CardiAMP cell therapy and allogeneic CardiALLO cell therapy.

Medivir AB announces that the number of shares and votes in Medivir has changed during January 2024 as a result of the rights issue resolved on by Medivir on 7 November 2023 and the directed issue to Hallberg Management AB resolved on by Medivir on 22 January 2024.

IRLAB Therapeutics announced that the company will hold a presentation in conjunction with the publication of the Year-end report for the period January-December 2023.

MetrioPharm AG announced that results from its clinical trial CT-05 in hospitalized patients with moderate to severe COVID-19 have been published in the renowned journal The Lancet Regional Health – Europe.

Immunovia announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.

Vizient, Inc. announced it is accepting applications for its 2024 Innovative Technology Exchange and encouraged suppliers of medical equipment and technology who want to showcase their products to health care decision makers from across the country to participate.